The Influence of Concurrent Oral Calcium Carbonate Supplementation on Steady State Pharmacokinetics of Oral Raltegravir.

NCT04258475 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Calcium Supplementation in HIV Patients Using Raltegravir

Interventions

DRUG: Raltegravir standard dosage of 1200 mg (two 600 mg tablets) orally once daily.
DRUG: Calcium carbonate antacid tablet

Sponsor

Ottawa Hospital Research Institute